MDA
MRK icon

Minot DeBlois Advisors’s Merck MRK Stock Holding History

Minot DeBlois Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.6K Sell
323
-10
-3% -$1.17K 0.04% 116
2026
Q1 		$40.1K Buy
333
+233
+233% +$26.9K 0.04% 115
2025
Q4 		$10.6K Sell
100
-318
-76% -$29.9K 0.01% 123
2025
Q3 		$35.1K Sell
418
-25
-6% -$2.06K 0.03% 115
2025
Q2 		$35.1K Hold
443
– – 0.03% 120
2025
Q1 		$39.8K Sell
443
-5
-1% -$467 0.04% 114
2024
Q4 		$44.6K Buy
+448
New +$46.2K 0.04% 126

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Minot DeBlois Advisors's MRK Position: Q2 2026 in Review

Minot DeBlois Advisors reduced its Merck (MRK) stake by 3% in Q2 2026, selling an estimated $1.17K and leaving 323 shares worth $41.6K. The position accounts for 0.04% of the portfolio, ranked #116.

Minot DeBlois Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $44.6K in Q4 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Minot DeBlois Advisors held 323 shares of Merck worth $41.6K as of Q2 2026.
  • Minot DeBlois Advisors sold 10 Merck shares in Q2 2026, an estimated $1.17K.
  • Merck made up 0.04% of Minot DeBlois Advisors's portfolio in Q2 2026, its #116 holding.
  • Minot DeBlois Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Minot DeBlois Advisors's Merck position peaked at $44.6K in Q4 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Minot DeBlois Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.